Refine by
Diagnostics Development Articles & Analysis: Older
137 news found
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...
Protheragen is proud to release the launch of its comprehensive vaccine development solutions tailored to advance research and development in the field of infectious diseases. ...
Recent years have witnessed the development of a series of disease models for cardiovascular disease research, such as cardiac organoid models and cardiomyocyte models, which greatly contribute to the basic research on the pathogenic mechanisms of various cardiovascular diseases and the development of new therapeutic methods. Ace Therapeutics’ new suite ...
By providing expertise and comprehensive solutions, Creative Diagnostics enables researchers and manufacturers to advance vaccine development and bioprocess efficiency. ...
This technique plays a crucial role in various research fields, including molecular biology, biochemistry, and diagnostics. With its expertise in chemical synthesis, Alfa Chemistry has become a proven and reliable provider of biotinylation reagents for scientists and researchers worldwide. ...
To date, several clinical trials have been completed using viral and non-viral vectors to deliver the P53 gene either alone or in combination with other therapeutic agents. Creative Diagnostics has developed a panel of high-quality materials to assist customers worldwide in their research into the functions, oncogenic pathways, and potential treatment of P53 and ...
Moreover, lectins have garnered attention in the commercial sphere, paving the way for the development of diagnostic tools, therapeutic agents, and food additives. ...
Biopharma PEG, a leading name in the pharmaceutical industry, is proud to announce a groundbreaking advancement in the field of Antibody-Drug Conjugate (ADC) development. The company now offers monodispersed Polyethylene Glycols (PEGs) on a scale ranging from grams to kilograms, and even on a ton scale. ...
Moreover, Daptomycin ReadyMade™ Solution will enable precise and consistent dilutions, guaranteeing the most accurate and reproducible results in research, pharmaceutical development, and diagnostic applications. The solution's stability and long shelf-life further ensure uninterrupted availability, promoting increased productivity and cost-effectiveness ...
With expertise in antibody generation and immunoassay development, Creative Diagnostics can generate various diagnostic antibodies covering a wide range of diseases, including infectious diseases, cardiovascular diseases, cancer and bone diseases, especially osteoporosis. ...
“These additional resources will support our recently launched commercial services which, for the first time, will provide the pharmaceutical and biobanking industries with access to our proprietary metabolic database, as well as to our advanced interpretive software to assist in various phases of drug research, development, and manufacturing,” said Dr. Ali Tinazli, ...
About ImmunogenX ImmunogenX, Inc. is a clinical-stage biopharmaceutical company founded in 2013 and is supported by a team of world-renowned clinicians, scientists and advisors in celiac disease research. The company is developing latiglutenase (IMGX003) for celiac disease therapy. ImmunogenX is also developing a diagnostic tool for celiac ...
Creative Enzymes is a leading biotechnology company supporting the development of diagnostic enzymes for kidney and pancreatic diseases. ...
The increased importance of gene fusions in oncology is driving demand from diagnostic laboratories for scalable analytical solutions. RNA can be used to analyze gene fusions. ...
Qlucore, trusted by scientists since 2007, is developing two new software packages for clinical RNA-seq data analyses. ...
Creative Diagnostics' monkeypox virus antigens are expressed in E. coli or HEK293 cells and are manufactured at a purity level of > 90%, suitable for ELISA and lateral flow assays and can be used to develop diagnostic assays. ...
NanoPin Technologies Inc, a biotechnology company focused on developing advanced diagnostics to improve the lives of millions of individuals affected by infectious diseases worldwide, announced the release of a scientific study conducted by founder Tony Hu, Ph.D. ...
Oxford, UK, 29th March 2022. Oxford Brain Diagnostics, a software company focused on developing diagnostics that identify changes in the brain at a cellular level, today announced that their Cortical Disarray Measurement (CDM®) has been appointed as a secondary outcome measure for a Randomized, PlaceboControlled, Double-Blind Study of ...
The Muscular Dystrophy Association is pleased to announce the award of an MDA Venture Philanthropy (MVP) grant totaling $233,200 to Scottsdale, Ariz.-based Iron Horse Diagnostics to support development of a prognostic test for ALS (amyotrophic lateral sclerosis). ...
BynVector
Anavasi Diagnostics ('Anavasi'), a medical technology company focused on the development of novel molecular diagnostic testing, recently announced the addition of a Chief Financial Officer, Chief Operating Officer and Chief Commercial Officer to its management roster. ...